Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
dc.contributor.author | Kruger, Mariana![]() |
|
dc.contributor.author | Reynders, David![]() |
|
dc.contributor.author | Omar, Fareed E.![]() |
|
dc.contributor.author | Schoeman, Judy![]() |
|
dc.contributor.author | Wedi, Opope Oyaka![]() |
|
dc.contributor.author | Harvey, J.![]() |
|
dc.date.accessioned | 2015-02-12T12:57:26Z | |
dc.date.available | 2015-02-12T12:57:26Z | |
dc.date.issued | 2014-12 | |
dc.description.abstract | INTRODUCTION : Retinoblastoma (RB) is the most common eye cancer in children. Early detection is necessary for cure. OBJECTVE : To compare stage and outcome of children with RB treated at Kalafong Hospital, Pretoria, South Africa (SA), during two time periods (1993 - 2000 and 2001 - 2008, after outreach interventions in 2000 and introduction of compulsory community service for doctors in 1998). METHODS : Data collected included demography (age, gender, date of birth), stage and treatment received. The main outcome measure was disease-free survival and the study end-point was 60 months after diagnosis. RESULTS : There were 51 patients during the time period 1993 - 2000 (group 1) and 73 during 2001 - 2008 (group 2), with median ages of 32 and 26 months, respectively (marginally significantly younger in group 2; p=0.046). In group 1, the majority (57%) presented with advanced disease (stages III and IV), with a decline in this proportion in group 2 (40%) indicating a downward but not significant trend (p=0.075). Bilateral disease was diagnosed in 22% of patients in group 1 and 33% in group 2. Overall survival was 33% and 43% for groups 1 and 2, respectively. Excluding absconding patients, event-free survival was 50% in group 1, improving to 68% in group 2 (not statistically significant; p=0.18). Fewer patients needed radiotherapy during the second period (statistically significant; p=0.04), probably because of less advanced disease. CONCLUSION : Poor outcome is probably a result of late diagnosis. It is important to implement a strategy that will ensure early diagnosis and optimal management of RB in SA. | en_ZA |
dc.description.librarian | hb2015 | en_ZA |
dc.description.uri | http://www.samj.org.za | en_ZA |
dc.identifier.citation | Kruger, M, Reynders, D, Omar, F, Schoemna, J, Wedi, O & Harvey, J 2014, 'Retinoblastoma outcome at a single institution in South Africa', South African Medical Journal, vol. 104, no. 12, pp. 859-863. | en_ZA |
dc.identifier.issn | 0256-9574 (print) | |
dc.identifier.issn | 2078-5135 (online) | |
dc.identifier.other | 10.7196/SAMJ.8255 | |
dc.identifier.uri | http://hdl.handle.net/2263/43655 | |
dc.language.iso | en | en_ZA |
dc.publisher | South African Medical Journal | en_ZA |
dc.rights | © 2014 Health & Medical Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0). | en_ZA |
dc.subject | Retinoblastoma (RB) | en_ZA |
dc.subject | Eye cancer in children | en_ZA |
dc.subject | South Africa (SA) | en_ZA |
dc.title | Retinoblastoma outcome at a single institution in South Africa | en_ZA |
dc.type | Article | en_ZA |